Alpro Group and AGTC Genomics bring precision medicine to Malaysia
Medication errors and adverse drug reactions (ADRs) are major health concerns globally, with ADRs being a leading cause of hospitalisations. In Malaysia, about 1 in 10 hospitalised patients experience an ADR, with over 30% of these incidents being preventable. These errors also come with a hefty financial cost, making the need for safer, more personalised […]
Alpro Group and AGTC Genomics bring precision medicine to Malaysia Read More »